Rate limiting steps in metabolite kinetics: formation of 5-acetylaminosalicylate after administration of 5-aminosalicylate
Houston, J.B.; Cassidy, M.K.
Journal of Pharmacy and Pharmacology 34(8): 536-538
1982
ISSN/ISBN: 0022-3573 PMID: 6126573 Document Number: 185259
Document emailed within 1 workday
Related Documents
Otsuji, S.; Setoyama, S. 1973: Glycolytic rate limiting enzymes and polyamines in blood cell. I. Leukocyte glycolytic rate limiting enzymes in diabetes mellitus Rinsho Byori. Japanese Journal of Clinical Pathology 21(8): 669-672Teunissen, M.W.; De Leede, L.G.; Boeijinga, J.K.; Breimer, D.D. 1985: Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state Journal of Pharmacology and Experimental Therapeutics 233(3): 770-775
Iqbal, Z.M.; Epstein, S.S.; Krull, I.S.; Goff, U.; Mills, K.; Fine, D.H. 1980: Kinetics of nitrosamine formation in mice following oral administration of trace-level precursors Iarc Scientific Publications 31: 169-182
Ziegler, M.; Blanck, J.; Greschner, S.; Lenz, K.; Lau, A.; Ruckpaul, K. 1983: Kinetics of elementary steps in the cytochrome P-450 reaction sequence. V. Laser temperature-jump investigation of the spin relaxation kinetics of cytochrome P-450 LM2 Biomedica Biochimica Acta 42(6): 641-649
Lindenbaum, A.; Marcher, K.; Wepierre, J.; Cohen, Y. 1974: Blood-brain barrier: I. Kinetics of the distribution of amphetamine H3-in brain structures of the rate after intravenous administration Archives Internationales de Pharmacodynamie et de Therapie 212(2): 337-347
Yu, V.C.; de Lamirande, E.; Horning, M.G.; Pang, K.S. 1982: Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(6): 568-572
Fuhr, U.; Kober, S.; Zaigler, M.; Mutschler, E.; Spahn-Langguth, H. 2005: Rate-limiting biotransformation of triamterene is mediated by CYP1A2 International Journal of Clinical Pharmacology and Therapeutics 43(7): 327-334
Miller, L.G.; Thompson, M.L.; Byrnes, J.J.; Greenblatt, D.J.; Shemer, A. 1992: Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine Journal of Clinical Psychopharmacology 12(5): 341-345
Hendry, J.H.; Roberts, S.A.; Lord, B.I. 1994: Is hematopoiesis or its regulatory microenvironment the rate-limiting factor for LD50/30? Experimental Hematology 22(1): 2; Author Reply 3-4
Eadsforth, C.V.; Logan, C.J.; Page, J.A.; Regan, P.D. 1985: N-Butylglycidyl ether: the formation of a novel metabolite of an epoxide Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(2): 263-264
Wedlund, P.J.; Sweetman, B.J.; Wilkinson, G.R.; Branch, R.A. 1987: Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(2): 277-279
Shamina, N.V.; Mukhina, Z.M.; Kovaleva, N.M.; Filiurina, V.A. 2011: The steps of mobile phragmoplast formation in meiosis with successive cytokinesis Tsitologiia 53(2): 150-158
Schoenfield, L.J.; Bonorris, G.G.; Ganz, P. 1973: Induced alterations in the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in the hamster Journal of Laboratory and Clinical Medicine 82(6): 858-868
Schlossmann, K.; Pütter, J. 1973: Studies on the formation of the lactone and acid form of the main metabolite of mefruside Arzneimittel-Forschung 23(2): 255-262
Pietrabissa, A.; Di Stefano, R.; Collecchi, P.; Campanella, P.G.; Della Capanna, S.; Scarcello, E.; Turini, L.; Bevilacqua, G.; Mosca, F. 1994: Effect of cyclosporine-A pretreatment on lidocaine metabolite formation in the regenerating rat liver Transplantation Proceedings 26(5): 2908-2909
Schwarzl, I.; Stark, U.; Brodmann, M.; Haiden, U.; Tritthart, H.A.; Stark, G. 2000: Efficacy of the novel calcium antagonist R(+)-semotiadil in limiting the ventricular rate during atrial flutter in isolated guinea pig hearts Journal of Cardiovascular Pharmacology 35(2): 309-314
Crépin, M.; Lelong, J.C.; Gros, F. 1973: Early steps in the formation of a translation initiation complex on newly transcribed messenger RNA Acta Endocrinologica. Supplementum 180: 33-35
Mosbach, E.H. 1972: Hepatic synthesis of bile acids. Biochemical steps and mechanisms of rate control Archives of Internal Medicine 130(4): 478-487
Grech-Bélanger, O.; Turgeon, J.; Lalande, M.; Bélanger, P.M. 1991: Meta-hydroxymexiletine, a new metabolite of mexiletine. Isolation, characterization, and species differences in its formation Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 458-461
Cummings, J.; Milroy, R. 1986: In vitro formation of a toxic aglycone metabolite of 4-demethoxydaunorubicin in conditions that parallel the stomach Anticancer Research 6(5): 1177-1179